Coeptis Therapeutics science ‘furthering beautifully,’ CEO says
PremiumThe FlyCoeptis Therapeutics science ‘furthering beautifully,’ CEO says
5M ago
Coeptis stock ‘heavily undervalued,’ CEO Mehalick tells The Fly
Premium
The Fly
Coeptis stock ‘heavily undervalued,’ CEO Mehalick tells The Fly
5M ago
Coeptis CEO sees ‘extraordinarily wide opportunity’ in very large areas
Premium
The Fly
Coeptis CEO sees ‘extraordinarily wide opportunity’ in very large areas
5M ago
Coeptis Therapeutics names Colleen Delaney as chief scientific, medical officer
PremiumThe FlyCoeptis Therapeutics names Colleen Delaney as chief scientific, medical officer
1y ago
Coeptis Therapeutics initiated with a Buy at JonesResearch
Premium
The Fly
Coeptis Therapeutics initiated with a Buy at JonesResearch
2y ago
Coeptis Rises on Key Assets Acquisition from Deverra
Premium
Market News
Coeptis Rises on Key Assets Acquisition from Deverra
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100